Elevated immune activity following an anticancer combination therapy of a novel oncolytic immunotherapeutic agent, CAVATAK (Coxsackievirus A21), and immune checkpoint blockade
- Resource Type
- Journal
- Source
CANCER RESEARCH ; JUL 2016, 76 4p. Supplement: 14- Subject
- Language
- English
- ISSN
- 15387445